ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Silencing circular RNA-friend leukemia virus integration 1 restrained malignancy of CC cells and oxaliplatin resistance by disturbing dyskeratosis congenita 1

Liu, Weipeng*; Jiang, Hong; Li, Yuanqiang1
Open Life Sciences2022-5-18DOI: 10.1515/biol-2022-0036
2被引17阅读
引用收藏
分享

摘要

Circular-RNA friend leukemia virus integration 1 (circ-FLI1; hsa_circ_0000370) is a noninvasive biomarker for the diagnosis of colon carcinoma (CC). Herein, we intended to investigate its functions and competing endogenous RNA (ceRNA) mechanisms in CC cells. In terms of expression status, circ-FLI1 was abnormally upregulated in CC patients' tumors and cells, paralleled with DKC1 upregulation and miR-197-3p downregulation. Most strikingly, there was a direct target relationship between miR-197-3p and circ-FLI1 or DKC1 based on the starbase database, dual-luciferase reporter assay, and RNA immunoprecipitation. Functionally, the colony formation assay, MTS method, fluorescence-activated cell sorting method, cell cycle and apoptosis assays, and transwell assays were performed, and the results revealed that interfering circ-FLI1 and re-expressing miR-197-3p could restrict colony formation, cell viability, cell cycle progression, and migration/invasion of CC cells with apoptosis rate elevation; besides, they promoted oxaliplatin (L-OHP)-induced cell viability inhibition. Furthermore, there were counteractive effects between circ-FLI1 silencing and miR-197-3p depletion, miR-197-3p overexpression and DKC1 restoration on regulating CC cell functions and L-OHP resistance. With a xenograft tumor model, the anti-growth role of circ-FLI1 silencing was also found in vivo with or without L-OHP treatment. Collectively, we demonstrated that circ-FLI1 might confer L-OHP resistance and malignant progression of CC presumably through the circ-FLI1/miR-197-3p/DKC1 ceRNA axis.

学科与关键词

关键词
circ-FLI1miR-197-3pDKC1CC
相关
加载中…
  • CircCTNNA1 acts as a ceRNA for miR-363-3p to facilitate the progression of colorectal cancer by promoting CXCL5 expression
    Zhang, Yan; Zheng, Sheng; Liao, Nansheng; Huang, Huifeng; Chen, Wenxiao; Wu, Zhenxing; Wu, Deqing*Journal of Biological Research-Thessaloniki, 2021, 28(1): 7.被引 15
  • Identification of the tumor-suppressive role of circular RNA-FOXO3 in colorectal cancer via regulation of miR-543/LATS1 axis
    Deng, Yun-Yao; Min, Yu-Juan; Zhou, Kun; Yang, Qing-Song; Peng, Mei; Cui, Zhao-Rui; Zhu, Xiang-Lian; Liu, Hao; Wang, Min; Zhang, Xie*; Liu, Li-Xin*Oncology Reports, 2021, 46(5): 239.被引 6
  • Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages
    Wu, Siyuan; Lv, Xiaozhi; Wei, Haigang; Chen, Wuya; Zheng, Junming; Li, Xia; Song, Jing; Ai, Yilong*; Zou, ChenJournal of Cellular and Molecular Medicine, 2023, 27(24): 4133-4144.
查看全部 →

发表信息

论文状态
公开发表
期刊
Open Life Sciences
发表日期
2022-05-18
卷期
第 17 卷, 第 1 期
页码
563-576
DOI
10.1515/biol-2022-0036
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • L

    Liu, Weipeng (通讯) (第一作者)

    1 · china three gorges univ

  • J

    Jiang, Hong

    1 · china three gorges univ

查看全部 3 位作者收起作者
  • L

    Li, Yuanqiang

    1 · china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417